InvestSMART

PharmAust Limited (ASX: PAA) - Announcements

Current share price for PAA : $0.230 0.015 (6.98%)+

ASX company news and announcements for PharmAust Limited (PAA) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All PharmAust Limited (PAA) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than PharmAust Limited (PAA), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for PharmAust Limited (PAA)

Market Cap ($m) Headline Release
date/time+
Price at
release+
Current
price+
Gain/Loss View
- Appendix 2A & s708 notice (exercise of options) 15 Jul 2020 4:54PM $0.210 $0.230 risen by 9.52%
- Final Report delivered under Option Agreement 13 Jul 2020 9:24AM $0.215 $0.230 risen by 6.98%
- Appendix 2A & s708 notice (exercise of options) 10 Jul 2020 5:38PM $0.215 $0.230 risen by 6.98%
- Appendix 2A & s708 notice (exercise of options) 7 Jul 2020 5:01PM $0.220 $0.230 risen by 4.55%
- PharmAust Shareholder Update 24 Jun 2020 9:49AM $0.135 $0.230 risen by 70.37%
- Reinstatement to Official Quotation 18 Jun 2020 9:38AM $0.110 $0.230 risen by 109.09%
- Confirmation of Preliminary COVID-19 Results 18 Jun 2020 9:38AM $0.110 $0.230 risen by 109.09%
- Voluntary Suspension 15 Jun 2020 9:23AM $0.110 $0.230 risen by 109.09%
- Trading Halt 11 Jun 2020 9:38AM $0.110 $0.230 risen by 109.09%
- Virtual Investor Briefing Presentation 10 Jun 2020 8:50AM $0.115 $0.230 risen by 100%
- Virtual Investor Briefing 5 Jun 2020 8:20AM $0.115 $0.230 risen by 100%
- Reinstatement to Official Quotation 4 Jun 2020 9:20AM $0.097 $0.230 risen by 137.11%
- Preliminary Positive Results for the Treatment of SARS-CoV-2 4 Jun 2020 9:20AM $0.097 $0.230 risen by 137.11%
- Suspension from Official Quotation 2 Jun 2020 10:23AM $0.097 $0.230 risen by 137.11%
- Trading Halt 29 May 2020 1:41PM $0.097 $0.230 risen by 137.11%
- Pause in Trading 29 May 2020 1:34PM $0.097 $0.230 risen by 137.11%
- Monepantel Trial Achieves Successful Anti-Cancer Outcome 12 May 2020 9:25AM $0.100 $0.230 risen by 130%
- Trading Halt 8 May 2020 9:39AM $0.100 $0.230 risen by 130%
- Appendix 3G 30 Apr 2020 6:11PM $0.100 $0.230 risen by 130%
- Appendix 4C and Quarterly Update 20 Apr 2020 8:17AM $0.098 $0.230 risen by 134.69%
- PharmAust to Evaluate Monepantel on COVID-19 17 Apr 2020 9:27AM $0.080 $0.230 risen by 187.50%
- Expiry of Options 31 Mar 2020 6:41PM $0.068 $0.230 risen by 238.24%
- Phase II Dog Cancer Trial Update 31 Mar 2020 11:55AM $0.062 $0.230 risen by 270.97%
- Brisbane Animal Hospital Joins Phase II Dog Cancer Trial 3 Mar 2020 8:19AM $0.082 $0.230 risen by 180.49%
- Appendix 4D & Half Year Report 28 Feb 2020 2:39PM $0.082 $0.230 risen by 180.49%

351 - 375 of 796 results

Page 15 of 32

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.